Skip to Content

Erlotinib

In the US, Erlotinib (erlotinib systemic) is a member of the drug class EGFR inhibitors and is used to treat Non-Small Cell Lung Cancer, Pancreatic Cancer and Renal Cell Carcinoma.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE03

CAS registry number (Chemical Abstracts Service)

0183321-74-6

Chemical Formula

C22-H23-N3-O4

Molecular Weight

393

Therapeutic Category

Cytostatic agent: Epidermal growth factor receptor tyrosine kinase inhibitor

Chemical Names

4-Quinazolinamine, N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)-,

N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)chinazolin-4-amin (IUPAC)

N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)quinazolin-4-amine (WHO)

Foreign Names

  • Erlotinibum (Latin)
  • Erlotinib (German)
  • Erlotinib (French)
  • Erlotinib (Spanish)

Generic Names

  • Erlotinib (OS: BAN)
  • Erlotinib Hydrochloride (OS: USAN, BANM, JAN)
  • CP-358,774-01 (IS)
  • NSC 718781 (IS)
  • OSI-774 (Osi) (IS)
  • R-1415 (IS)

Brand Names

  • Bioborz
    Biosidus, Argentina
  • Erleva
    Glenmark, India
  • Erlotinib Alpha-Medical
    Alpha-Medical, Croatia (Hrvatska)
  • Erlotinib Glenmark
    Glenmark, Romania
  • Erlotinib Heaton
    Heaton, Romania
  • Erlotinib Mylan
    Mylan, Romania
  • Erlotinib PharmaS
    PharmaS, Croatia (Hrvatska)
  • Erlotinib Pliva
    Pliva, Croatia (Hrvatska)
  • Erlotinib ratiopharm
    Ratiopharm, Romania
  • Ertinob
    Nobel, Turkey
  • Postep
    Bago, Argentina
  • Robtor
    Kemex, Argentina
  • Tarcenib
    Techno Drugs, Bangladesh
  • Tarceva
    Roche, Colombia; Roche, Cyprus; Roche, Finland; Roche, Hong Kong; Roche, Lebanon; Roche, Philippines; Roche, Paraguay; Roche, Turkey; Roche, Vietnam; Roche Farma, Peru
  • Tarceva 100mg
    Roche, Israel; Roche, Oman
  • Tarceva 150mg
    Roche, Israel; Roche, Oman
  • Tarceva 25mg
    Roche, Oman
  • Varlota
    Alvogen, Croatia (Hrvatska); Alvogen, Lithuania; Alvogen, Latvia; Alvogen Malta, Romania; Remedica, Bulgaria
  • Apo-Erlotinib
    Apotex, Canada
  • Erloter
    Tuteur, Argentina
  • Erlotinib
    Actavis, Bosnia & Herzegowina; BGP Products, Bosnia & Herzegowina; Lek, Bosnia & Herzegowina; Mylan Ireland, Bosnia & Herzegowina; Teva, United Kingdom
  • Erlotinib Actavis
    Actavis Baltics Eesti, Estonia; Actavis Group, Malta
  • Erlotinib Amarox
    Hetero Europe, United Kingdom; Hetero Europe, Netherlands
  • Erlotinib Apotex
    Apotex Europe, Netherlands
  • Erlotinib BioOrganics
    BioOrganics, Netherlands
  • Erlotinib CF
    Centrafarm, Netherlands
  • Erlotinib Housthon
    Housthon BV, Netherlands
  • Erlotinib Hydrochloride Sandoz
    Sandoz, United Kingdom
  • Erlotinib Mylan
    Mylan, Sweden; Mylan Healthcare, Estonia; PharOS, Netherlands
  • Erlotinib ratiopharm
    Teva, Sweden
  • Erlotinib Sandoz
    Sandoz, Estonia; Sandoz, Romania
  • Erlotinib Sandoz 100mg
    Sandoz, Switzerland
  • Erlotinib Sandoz 150mg
    Sandoz, Switzerland
  • Erlotinib Sandoz 25mg
    Sandoz, Switzerland
  • Erlotinib Stada
    STADA Nordic, Sweden
  • Erlotinib Teva
    Merckle, Bulgaria; Pliva, Bulgaria; Teva, Bulgaria; Teva, Bulgaria; Teva, Sweden; Teva Eesti, Estonia; Teva Nederland, Netherlands; Teva Operations Poland, Bulgaria; Teva Romania, Romania
  • Erlotinib Teva Pharma
    Teva Eesti, Estonia
  • Erlotinib Zentiva
    Zentiva, Netherlands
  • Erlotinib-Humanity
    BDR Pharmaceuticals, Georgia
  • Ertinob
    Nobel, Georgia
  • Mitroxelen
    Remedica, Bosnia & Herzegowina
  • PMS-Erlotinib
    Pharmascience, Canada
  • Tarceva
    Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche, Canada; OSI Pharma, United States; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, France; Roche, Georgia; Roche, Georgia; Roche, Greece; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Latvia; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Poland; Roche, Portugal; Roche, Sweden; Roche, Thailand; Roche, Taiwan; Roche, South Africa; Roche - Germania, Romania; Roche Pharmaceutical, China; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay; Roche, Lithuania
  • Tarceva 100 mg
    Roche, Hungary
  • Tarceva 100mg
    Roche, Germany; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Tarceva 150 mg
    Roche, Hungary
  • Tarceva 150mg
    Roche, Germany; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Tarceva 25mg
    Roche, Germany; Roche Pharma Schweiz, Switzerland
  • Teva-Erlotinib
    Teva Canada, Canada
  • Tirleb
    LKM, Argentina
  • Varlota
    Alvogen, Estonia; Alvogen Malta, Iceland; Remedica, Bosnia & Herzegowina

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide